Back to top

rating-upgrade: Archive

Zacks Equity Research

The LGL Group (LGL) Upgraded to Buy: What Does It Mean for the Stock?

The LGL Group (LGL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

LGLPositive Net Change

Zacks Equity Research

Plumas Bancorp (PLBC) Moves to Buy: Rationale Behind the Upgrade

Plumas Bancorp (PLBC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PLBCPositive Net Change

Zacks Equity Research

Klabin (KLBAY) Upgraded to Buy: Here's Why

Klabin (KLBAY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

KLBAYPositive Net Change

Zacks Equity Research

Monolithic (MPWR) Upgraded to Buy: What Does It Mean for the Stock?

Monolithic (MPWR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MPWRNegative Net Change

Zacks Equity Research

What Makes Ralliant (RAL) a New Strong Buy Stock

Ralliant (RAL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

RALNegative Net Change

Zacks Equity Research

All You Need to Know About BeOne Medicines Ltd. - Sponsored ADR (ONC) Rating Upgrade to Strong Buy

BeOne Medicines Ltd. - Sponsored ADR (ONC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ONCPositive Net Change

Zacks Equity Research

Western Midstream (WES) Upgraded to Strong Buy: Here's What You Should Know

Western Midstream (WES) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

WESPositive Net Change

Zacks Equity Research

Protagonist Therapeutics (PTGX) Upgraded to Strong Buy: Here's What You Should Know

Protagonist Therapeutics (PTGX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PTGXPositive Net Change

Zacks Equity Research

CarMax (KMX) Upgraded to Strong Buy: Here's Why

CarMax (KMX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

KMXPositive Net Change

Zacks Equity Research

Oddity Tech (ODD) Upgraded to Strong Buy: Here's What You Should Know

Oddity Tech (ODD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ODDPositive Net Change